Amsurg Corp Earns Neutral Rating from Analysts at Goldman Sachs (AMSG)
Equities researchers at Goldman Sachs initiated coverage on shares of Amsurg Corp (NASDAQ:AMSG) in a research report issued on Wednesday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating on the stock.
Other equities research analysts have also recently issued reports about the stock. Analysts at Piper Jaffray raised their price target on shares of Amsurg Corp from $45.00 to $51.00 in a research note on Monday, August 4th. Separately, analysts at SunTrust upgraded shares of Amsurg Corp from a “neutral” rating to a “buy” rating in a research note on Friday, June 27th. They now have a $54.00 price target on the stock, up previously from $50.00. Finally, analysts at Robert W. Baird upgraded shares of Amsurg Corp from a “neutral” rating to an “outperform” rating in a research note on Friday, June 27th. They now have a $55.00 price target on the stock, up previously from $44.00. Three analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $54.29.
Amsurg Corp (NASDAQ:AMSG) opened at 53.95 on Wednesday. Amsurg Corp has a one year low of $36.55 and a one year high of $54.48. The stock’s 50-day moving average is $49.6 and its 200-day moving average is $46.77. The company has a market cap of $1.719 billion and a P/E ratio of 23.84.
Amsurg Corp (NASDAQ:AMSG) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.63 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.63. The company had revenue of $281.10 million for the quarter, compared to the consensus estimate of $281.51 million. During the same quarter last year, the company posted $0.58 earnings per share. Amsurg Corp’s revenue was up 5.2% compared to the same quarter last year. Analysts expect that Amsurg Corp will post $2.47 EPS for the current fiscal year.
AmSurg Corp. is the owner and operator of short stay ambulatory surgery centers (NASDAQ:AMSG) in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.